Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for Treatment of Oropharyngeal and Esophageal Candidiases

Practice Guidelines for the Treatment of Candidiasis

Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927

Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections

Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A., Lancaster, M., Odds, F. C., Rinaldi, M. G., Walsh, T. J., et al. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.235 · Cited by 855

Epidemiology of Human Immunodeficiency Virus–Associated Opportunistic Infections in the United States in the Era of Highly Active Antiretroviral Therapy

Kaplan, J. E., Hanson, D. L., Dworkin, M. S., Frederick, T., Bertolli, J., Lindegren, M. L., Holmberg, S. D., & Jones, J. L. (2000) · Clinical Infectious Diseases · doi:10.1086/313843 · Cited by 703

Lipid Formulations of Amphotericin B: Recent Progress and Future Directions

Hiemenz, J. W., & Walsh, T. J. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_2.s133 · Cited by 404

Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance

Sangeorzan, J. A., Bradley, S. F., He, X., Zarins, L. T., Ridenour, G. L., Tiballi, R. N., & Kauffman, C. A. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90300-x · Cited by 322

International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents

Pfaller, M. A., Jones, R. N., Doern, G. V., Fluit, A. C., Verhoef, J., Sader, H. S., Messer, S. A., Houston, A. K., Coffman, S. L., & Hollis, R. J. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00046-2 · Cited by 264

Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection

Ruhnke, M., Eigler, A., Tennagen, I., Geiseler, B., Engelmann, E., & Trautmann, M. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.9.2092-2098.1994 · Cited by 250

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

Abruzzo, G. K., Flattery, A. M., Gill, C. J., Kong, L., Smith, J. G., Pikounis, V. B., Balkovec, J. M., Bouffard, A., Dropinski, J. F., Rosen, H., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2333 · Cited by 241

Esophageal infections: Risk factors, presentation, diagnosis, and treatment

Baehr, P. H., & McDonald, G. B. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90613-0 · Cited by 214

Current and future antifungal therapy: new targets for antifungal agents

Andriole, V. T. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.2.151 · Cited by 191

Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation

Trenschel, R., Ditschkowski, M., Elmaagacli, A. H., Koldehoff, M., Ottinger, H., Steckel, N. K., Hlinka, M., Peceny, R., Rath, P., Dermoumi, H. L., et al. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704859 · Cited by 40

Mucosal and Systemic Fungal Infections in Patients with AIDS

Ruhnke, M. (2004) · Drugs · doi:10.2165/00003495-200464110-00002 · Cited by 38

The pathophysiology and treatment of Candida sepsis

Spellberg, B. J., & Edwards, J. E. (2002) · Current Infectious Disease Reports · doi:10.1007/s11908-002-0005-3 · Cited by 37

Population Pharmacokinetics and Pharmacodynamics of Caspofungin in Pediatric Patients

Li, C., Sun, P. G., Dong, Y., Bi, S., Desai, R., Dockendorf, M. F., Kartsonis, N. A., Ngai, A. L., Bradshaw, S. K., & Stone, J. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00905-10 · Cited by 36

Endocrine and Metabolic Manifestations of Invasive Fungal Infections and Systemic Antifungal Treatment

Lionakis, M. S., Samonis, G., & Kontoyiannis, D. P. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.9.1046 · Cited by 37

Fungal Infections: Their Diagnosis and Treatment in Transplant Recipients

Thiel, D. H. V., George, M., & Moore, C. M. (2012) · International Journal of Hepatology · doi:10.1155/2012/106923 · Cited by 38

Efficacy of PLD-118, a Novel Inhibitor of Candida Isoleucyl-tRNA Synthetase, against Experimental Oropharyngeal and Esophageal Candidiasis Caused by Fluconazole-Resistant C. albicans

Petraitis, V., Petraitienė, R., Kelaher, A. M., Sarafandi, A. A., Sein, T., Mickiene, D., Bacher, J. D., Groll, A. H., & Walsh, T. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3959-3967.2004 · Cited by 36

Atualização no uso de agentes antifúngicos

Martínez, R. (2006) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132006000500013 · Cited by 57

Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT

Egger, S. S., Meier, S., Leu, C.-Y., Christen, S. E., Gratwohl, A. A., Krähenbühl, S., & Haschke, M. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.325 · Cited by 35

Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient—case report and review of literature

Bacak, V., Biočina, B., Starčević, B., Gertler, S., & Begovać, J. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.10.003 · Cited by 34

Diagnose und Therapie von Pilzinfektionen und der Pneumozystis-Pneumonie bei Kindern und Jugendlichen mit neoplastischen Erkrankungen

Groll, A. H., & Ritter, J. (2005) · Klinische Pädiatrie · doi:10.1055/s-2005-872501 · Cited by 32

Invasive candidiasis: update on current pharmacotherapy options and future perspectives

Tragiannidis, A., Tsoulas, C., Kerl, K., & Groll, A. H. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.805204 · Cited by 34

Fungal Infections in Cancer Patients

Angarone, M. (2014) · Cancer treatment and research · doi:10.1007/978-3-319-04220-6_4 · Cited by 32

New agents for the treatment of systemic fungal infections – current status

Rex, J. H., & Arıkan, S. (2002) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.7.1.3 · Cited by 29

Caspofungin for the treatment of fungal infections: a systematic review of randomized controlled trials

Falagas, M. E., Ntziora, F., Betsi, G. I., & Samonis, G. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.09.018 · Cited by 28

The pharmacology and clinical use of caspofungin

Hope, W. W., Shoham, S., & Walsh, T. J. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.2.263 · Cited by 28

Candida tropicalis arthritis of the knee in a patient with acute lymphoblastic leukaemia: successful treatment with caspofungin.

Sim, J. P. Y., Kho, B. C. S., Liu, H. S. Y., Yung, R. W. H., & Chan, J. C. W. (2005) · PubMed · Cited by 28

Anidulafungin in the treatment of invasive fungal infections

Gumbo, T. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s882 · Cited by 26

Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin

Maschmeyer, G., & Glasmacher, A. G. (2005) · Mycoses · doi:10.1111/j.1439-0507.2005.01131.x · Cited by 26

Pharmacoeconomics of antifungal pharmacotherapy – challenges and future directions

Johnson, M. D., Kleinberg, M. E., Danziger, L. H., & Ostrosky-Zeichner, L. L. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.15.2617 · Cited by 25

Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children

Pienaar, E. D., Young, T., & Holmes, H. K. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003940.pub2 · Cited by 25

Comparative Efficacy of Antifungal Agents Used in the Treatment of Oropharyngeal Candidiasis among HIV-Infected Adults: A Systematic Review and Network Meta-Analysis

Rajadurai, S. G., Maharajan, M. K., Veettil, S. K., & Gopinath, D. (2021) · Journal of Fungi · doi:10.3390/jof7080637 · Cited by 24

The Use of Antifungal Therapy in Neonatal Intensive Care

Testoni, D., Smith, P. B., & Benjamin, D. K. (2012) · Clinics in Perinatology · doi:10.1016/j.clp.2011.12.008 · Cited by 24

Newer antifungal agents

Abuhammour, W., & Habte‐Gabr, E. (2004) · The Indian Journal of Pediatrics · doi:10.1007/bf02724279 · Cited by 25

The use of caspofungin in HIV-infected individuals

Waters, L. J., & Nelson, M. R. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.6.899 · Cited by 23

Efficacy and Safety of Caspofungin in Solid Organ Transplant Recipients

Petrovic, J., Ngai, A., Bradshaw, S. K., Williams‐Diaz, A., Taylor, A., Sable, C. A., Vuocolo, S. C., & Kartsonis, N. A. (2007) · Transplantation Proceedings · doi:10.1016/j.transproceed.2007.10.003 · Cited by 23

Clinical pharmacology of antifungal agents in pediatric patients

Chiou, C. C., Walsh, T. J., & Groll, A. H. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.15.2465 · Cited by 22

Aqueous Humor Concentrations of Topically Administered Caspofungin in Rabbits

Vorwerk, C. K., Tuchen, S., Streit, F., Binder, L., Hofmüller, W., & Behrens‐Baumann, W. (2008) · Ophthalmic Research · doi:10.1159/000187627 · Cited by 22

In vitroactivity of caspofungin compared to amphotericin B, fluconazole, and itraconazole againstCandidastrains isolated in a Turkish University Hospital

Arıkan, S., Sancak, B., & Hasçelik, G. (2005) · Medical Mycology · doi:10.1080/13693780410001731565 · Cited by 22

Guatemala articles in the Science Citation Index Expanded: bibliometry of subjects, collaboration, institutions and authors

Mónge-Nájera, J., & Ho, Y. (2017) · Revista de Biología Tropical · doi:10.15517/rbt.v66i1.29875 · Cited by 22

Caspofungin in the treatment of candidosis and aspergillosis

Maertens, J. A., & Boogaerts, M. (2003) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(03)90003-8 · Cited by 20

Efficacy of caspofungin in invasive candidiasis and candidemia – de‐escalation strategy

Lichtenstern, C., Nguyen, T. H., Schemmer, P., Hoppe‐Tichy, T., & Weigand, M. A. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01527.x · Cited by 20

Caspofungin is less nephrotoxic than amphotericin B in vitro and predominantly damages distal renal tubular cells

Wegner, B., Baer, P. C., Gauer, S., Oremek, G. M., Hauser, I. A., & Geiger, H. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh948 · Cited by 18

Echinocandins: a wealth of choice – how clinically different are they?

Zaas, A. K. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328307c79c · Cited by 19

Caspofungin: an advanced treatment approach for suspected or confirmed invasive aspergillosis

Maertens, J. A. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.03.019 · Cited by 18

Invasive fungal infection--laboratory diagnosis and antifungal treatment.

Shao, P. L., Huang, L., & Hsueh, P. (2006) · PubMed · Cited by 18

The safety of anidulafungin

Vázquez, J. A. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.6.751 · Cited by 18

Prophylaxis, empirical therapy, or pre-emptive therapy of fungal infections in immunocompromised patients: which is better for whom?

Leather, H. L., & Wingard, J. R. (2002) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200208000-00003 · Cited by 18

Caspofungin in a pediatric patient with persistent candidemia

Wertz, K. K., & Pretzlaff, R. K. (2004) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000113264.00053.af · Cited by 19

Efficacy and safety of caspofungin in obese patients

Ryan, D., Lupinacci, R. J., & Kartsonis, N. A. (2011) · Medical Mycology · doi:10.3109/13693786.2011.571293 · Cited by 16

Tratamiento de las infecciones fúngicas en pacientes con neoplasias hematológicas

Mensa, J., de la Cámara, R., Carreras, E., Estrella, M. C., Rodríguez, J. Á. G., Gobernado, M., Picazo, J., Aguado, J. M., & Sanz, M. Á. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2009.01.008 · Cited by 16

Drugs Active against Fungi, Pneumocystis, and Microsporidia

Rex, J. H., & Stevens, D. A. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00039-4 · Cited by 16

Fungal Infections After Hematopoietic Cell Transplantation

Brown, J. W. (2003) · Wiley eBooks · doi:10.1002/9780470987070.ch52 · Cited by 16

Physiology-Based Pharmacokinetics of Caspofungin for Adults and Paediatrics

Stader, F., Würthwein, G., Groll, A. H., Vehreschild, J. J., Cornely, O. A., & Hempel, G. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1595-9 · Cited by 15

Systemic Antifungal Agents

Rex, J. H., & Stevens, D. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00040-0 · Cited by 16

Caspofungin—a new therapeutic option for oropharyngeal candidiasis

Garbino, J. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1198-743x.2004.00823.x · Cited by 14

Caspofungin in the Treatment of Azole-Refractory Esophageal Candidiasis in Kidney Transplant Recipients

Veroux, M., Macarone, M., Fiamingo, P., Cappello, D., Gagliano, M., Mare, M. D., Vizcarra, D., Spataro, M., Giuffrida, G., Sorbello, M., et al. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.03.050 · Cited by 14

La caspofungine : du mécanisme d'action aux applications thérapeutiques

Datry, A., & Bart–Delabesse, E. (2005) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2005.05.012 · Cited by 14

Determination of the Relative and Absolute Configuration of the Dimethylmyristoyl Side Chain of Pneumocandin B0 by Asymmetric Synthesis

William R. Leonard, Belyk, K. M., Bender, D. R., Conlon, D. A., Hughes, D. L., & Reider, P. J. (2002) · Organic Letters · doi:10.1021/ol0261940 · Cited by 13

What’s new in antifungals?

Valgus, J. M. (2003) · Current Infectious Disease Reports · doi:10.1007/s11908-003-0060-4 · Cited by 14

Therapy of systemic fungal infections

Wu, J. J., Pang, K. R., Huang, D. B., & Tyring, S. K. (2004) · Dermatologic Therapy · doi:10.1111/j.1396-0296.2004.04057.x · Cited by 13

Anidulafungin: an evidence-based review of its use in invasive fungal infections.

Davis, S. L., & Vázquez, J. A. (2008) · PubMed Central · Cited by 12

Nongastroesophageal reflux disease-related infectious, inflammatory and injurious disorders of the esophagus

Pace, F., Pallotta, S., & Antinori, S. (2007) · Current Opinion in Internal Medicine · doi:10.1097/mog.0b013e32818a6d8b · Cited by 12

Efficacy and acceptability of different anti-fungal interventions in oropharyngeal or esophageal candidiasis in HIV co-infected adults: a pilot network meta-analysis

Zeng, B., Zeng, B., Hung, C., Chen, T., Wu, Y., Tu, Y., Lin, P., Su, K., Stubbs, B., Sun, C., et al. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1922078 · Cited by 12

Caspofungin: when and how? The microbiologist’s view

Mayr, A., Aigner, M., & Lass‐Flörl, C. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02039.x · Cited by 11

Inflammatory Disorders of the Esophagus

Bennett, A. E., Goldblum, J. R., & Odze, R. D. (2009) · Elsevier eBooks · doi:10.1016/b978-141604059-0.50014-x · Cited by 11

Caspofungin: a major breakthrough in treatment of systemic fungal infections.

Agarwal, M. B., Rathi, S., Ratho, N., & Subramanian, R. (2006) · PubMed · Cited by 11

Anidulafungin: an evidence-based review of its use in invasive fungal infections

Vazquez, J. (2007) · Core evidence · doi:10.2147/ce.s7433 · Cited by 10

Assessment of the In Vitro Kinetic Activity of Caspofungin against Candida glabrata

Nagappan, V., Boikov, D. A., & Vázquez, J. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01339-08 · Cited by 10

Antifungals: Drug Class, Mechanisms of Action, Pharmacokinetics/Pharmacodynamics, Drug-Drug Interactions, Toxicity, and Clinical Use

Nett, J. E., & Andes, D. R. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch22 · Cited by 10

Successful treatment of refractory chronic disseminated candidiasis after prolonged administration of caspofungin in a child with acute myeloid leukemia

Kontny, U., Walsh, T. J., Rössler, J. K., Uhl, M., & Niemeyer, C. M. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20751 · Cited by 10

Resistance to Antifungal Agents

Arthington, B. A., & Rex, J. H. (2007) · Springer eBooks · doi:10.1007/978-0-387-72418-8_10 · Cited by 9

Mucosal Candidiasis

Revankar, S. G., & Sobel, J. D. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch26 · Cited by 10

Liver cirrhosis as a predisposing factor for esophageal candidiasis

Ou, T., Huang, H., Hsieh, T., Chang, W., Chu, H.-C., Hsu, C., Shih, Y., Huang, T., Chen, P., & Lin, H. (2014) · Advances in digestive medicine · doi:10.1016/j.aidm.2013.09.005 · Cited by 9

Postoperative Management

Leone, J. P., Christensen, K., Bhargava, R., Hunter, D. W., Troppmann, C., Lazaron, V., Dunn, D. L., Paraskevas, S., Coad, J. E., & Gruessner, R. W. G. (2004) · Springer eBooks · doi:10.1007/978-1-4757-4371-5_9 · Cited by 8

Pharmacotherapy of Candida bloodstream infections: new treatment options, new era

Lewis, R. E. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.8.1039 · Cited by 8

Gastrointestinal infections in the immunocompromised host

Fantry, L. E. (2003) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200301000-00006 · Cited by 8

4 Gastrointestinal opportunistic infections

Beeching, N. J., Jones, R., & Gazzard, B. (2011) · HIV Medicine · doi:10.1111/j.1468-1293.2011.00944_5.x · Cited by 8

Nouveaux antifongiques : voriconazole et caspofungine

Dupont, B. (2003) · Archives de Pédiatrie · doi:10.1016/s0929-693x(03)90043-1 · Cited by 8

Systemic antifungal therapy for oesophageal candidiasis – systematic review and meta-analysis of randomized controlled trials

Mwassi, H. A., Yahav, D., Ayada, G., Matsri, S., Margalit, I., Shargian, L., Bishara, J., & Atamna, A. (2022) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2022.106590 · Cited by 8

[Recommendations of antifungal treatment in patients with low grade immunosuppression].

Barberán, J., Mensa, J., Fariñas, C., Llinares, P., Serrano, R., Menéndez, R., Agustí, C., Gobernado, M., Azanza, J. R., & Rodríguez, J. A. G. (2008) · PubMed · Cited by 14

COMPARISON OF CASPOFUNGIN AND AMPHOTERICIN B FOR INVASIVE CANDIDIASIS

Ora, J., Etts, R. O. B., Otstein, C. O. R., Rnaldo, A., Olombo, L. O. C., Hompson, L. U. T., Upinacci, R. O. L., Artsonis, I. K., Erfect, J. O. P., & Roup, S. T. G. (2002) · Cited by 7

Nueva aportación en terapia antifúngica: Anidulafungina. Aspectos farmacológicos de la anidulafungina

González, M. C., & González, J. C. M. (2008) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(08)70026-3 · Cited by 7

Combined Surgical and Medical Therapy for Candida Prosthetic Endocarditis in a Patient with Repaired Tetralogy of Fallot

Kubota, K., Soma, K., Uehara, M., Inaba, T., Saito, A., Takeda, N., Hatano, M., Morita, H., Inuzuka, R., Hirata, Y., et al. (2018) · International Heart Journal · doi:10.1536/ihj.17-314 · Cited by 6

Fungal Opportunistic Infections in HIV Disease

Duffalo, M. L. (2006) · Journal of Pharmacy Practice · doi:10.1177/0897190005284095 · Cited by 6

Caspofungin Effects on Electrocardiogram of Mice: An Evaluation of Cardiac Safety

de Paula, D. C. C., Leite, E. A., Araújo, C. M., Branquinho, R. T., Guimarães, H. N., & Grabe‐Guimarães, A. (2020) · Cardiovascular Toxicology · doi:10.1007/s12012-020-09599-x · Cited by 6

The Role of Resistance in Candida Infections: Epidemiology and Treatment

Sobel, J. D., & Akins, R. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-47266-9_18 · Cited by 6

Management of Oropharyngeal and Esophageal Candidiasis in Patients with Hiv Infection

Vazquez, J. A. (2010) · HIV Therapy · doi:10.2217/hiv.10.18 · Cited by 6

Avances en el diagnóstico y tratamiento de las infecciones por levaduras: papel de los nuevos antifúngicos

Pemán, J., & Almirante, B. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13128779 · Cited by 5

Synthetic antifungal compounds

Λιάρας, Κ., & Sokóvić, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815824-1.00005-6 · Cited by 5

Infectious Disease Update: New Anti-Microbials

Yang, A., & Kerdel, F. A. (2006) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2006.04.006 · Cited by 5

Nouveaux antifongiques et nouvelles stratégies thérapeutiques dans les aspergilloses et candidoses invasives

Bretagne, S. (2005) · Antibiotiques · doi:10.1016/s1294-5501(05)80161-x · Cited by 5

Antifungal Agents and Antifungal Susceptibility Testing

Revankar, S. G., Graybill, J. R., & Patterson, T. F. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0134 · Cited by 5

Caspofungin for the Treatment of Immunocompromised and Severely III Children and Neonates with Invasive Fungal Infections

Wiederhold, N. P., & Herrera, L. A. (2012) · Clinical Medicine Insights Pediatrics · doi:10.4137/cmped.s8016 · Cited by 6

The current place of echinocandins in the treatment and prophylaxis of invasive fungal infections

Veselov, A. V. (2020) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2020.3.197-209 · Cited by 6

Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antifungal Agents: A Review

Pecho, T., & Zeitlinger, M. (2023) · Clinical Pharmacokinetics · doi:10.1007/s40262-023-01327-2 · Cited by 4

Anidulafungin: advantage for the newcomer?

Rüping, M. J. G. T., Vehreschild, J. J., Farowski, F., & Cornely, O. A. (2008) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.1.2.207 · Cited by 4

Mucocutaneous and Deeply Invasive Candidiasis

Shoham, S., Nucci, M., & Walsh, T. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3935-5.00088-4 · Cited by 4

Echinocandins

Groll, A. H., Schrey, D., & Walsh, T. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_6 · Cited by 4

Echinocandins: Ask Not What They Can Do for Esophageal Candidiasis--Ask What Studies of Esophageal Candidiasis Can Do for Them

Darouiche, R. O. (2004) · Clinical Infectious Diseases · doi:10.1086/423391 · Cited by 4

Caspofungin: the first licensed antifungal drug of the novel echinocandin class

DiNubile, M. J., Motyl, M. R., & Sable, C. A. (2004) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2004.05.001 · Cited by 3

Double‐Blind Active‐Control Trials: Beware the Comparator You Keep

DiNubile, M. J. (2008) · Clinical Infectious Diseases · doi:10.1086/592068 · Cited by 3

Caspofungin in kidney transplant recipients with refractory invasive candidiasis

Veroux, M., Corona, D., Macarone, M., Gagliano, M., Giuffida, G., & Veroux, P. F. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl749 · Cited by 3

Resolution of azole-resistant oesophageal candidiasis in an AIDS patient after treatment with caspofungin

Smith, K., Youle, M. S., Baker, B., Ballinger, J., Cuthbertson, Z., & Johnson, M. A. (2003) · AIDS · doi:10.1097/00002030-200302140-00023 · Cited by 3

Actividad in vitro de caspofungina frente a aislados clínicos de Candida resistentes a fluconazol en pacientes con infección por el VIH

de la Tabla, V. O., Masiá, M., Martín-González, C., & Gutiérrez, F. (2004) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(04)73104-3 · Cited by 2

Diagnóstico y tratamiento de infecciones oportunistas en el paciente adulto con infección por VIH/SIDA

Martín Lasso, B. (2011) · Revista chilena de infectología · doi:10.4067/s0716-10182011000600010 · Cited by 2

Cancer and Fungal Infections

Uçar, S., Naik, A. Q., & Zafar, T. (2024) · Springer eBooks · doi:10.1007/978-981-97-6948-3_9 · Cited by 2

The Role of Resistance in Candida Infections: Epidemiology and Treatment

Sobel, J. D., & Akins, R. A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-595-8_18 · Cited by 2

Antifungal Therapy in Surgical ICU Patients

Weigand, M. A., Lichtenstern, C., & Böttiger, B. W. (2007) · Springer eBooks · doi:10.1007/0-387-35096-9_57 · Cited by 2

New developments in antifungal strategy

Shetty, A., & Barnes, R. A. (2004) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2.2.269 · Cited by 2

A Randomized Double-Blind Study of Caspofungin versus Amphotericin for the Treatment of Candidal Esophagitis

Sable, C. A. (2015)

Caspofungin vs. Amphotericin B for Oropharyngeal and Esophageal Candidiases

Lode, H. M. (2002) · Journal watch · doi:10.1056/id200202210000005

Caspofungin

Keating, G. M., & Figgitt, D. P. (2003) · Drugs · doi:10.2165/00003495-200363200-00008 · Cited by 75

Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis

Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380

A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis

Villanueva, A., Gotuzzo, E., Arathoon, E., Noriega, L. M., Kartsonis, N. A., Lupinacci, R. J., Smietana, J. M., DiNubile, M. J., & Sable, C. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01191-9 · Cited by 290